In August 2025, US cellulase enzyme prices continued to decline due to favorable macroeconomic and logistical conditions. Lower transpacific freight rates and a stronger US dollar against Asian currencies reduced import costs. Despite increased supply and competitive export quotations from Asian producers, Cellulase enzyme demand in the US remained subdued, with buyers opting for short-term contracts and cautious purchasing. However, a modest price rebound is anticipated by September 2025, driven by seasonal demand and rising energy costs in producing nations.
Key Highlights
-
Price Decline Continues: US cellulase enzyme prices continue to decline further in August xxxx, supported by persistent weaken demand, lower freight rates and dollar appreciation.
-
Supply-Side Dynamics: Producers across the Asian market ramped up production, increasing export availability. The result which competitive pricing made enzymes more accessible to US buyers.
-
Market Outlook for Qx End: Prices may rebound in September xxxx due to seasonal demand, an anticipated rise in energy costs impacting production expenses, and a potential uptick in production cycles ahead of the holiday season.
Yet again, the US cellulase enzyme prices continue to drop even in the month of August xxxx, driven by favorable macroeconomic and logistical factors. Other business interests had indicated that reduced freight costs on transpacific routes, and the strengthening of the dollar against the currencies of the producing country, reduced the landed cost of imports of cellulase enzyme into the United States...
